Reports
Search reports, investigative results, and agency plansShowing 1 - 10 of 31 results
Environmental Protection Agency OIG
EPA Should Consistently Track Coronavirus Pandemic-Related Grant Flexibilities and Implement Plan for Electronic Grant File Storage
The EPA Office of Grants and Debarment does not know the full extent to which program offices and regions have implemented grant flexibilities and exceptions permitted by the Office of Management and Budget due to the coronavirus pandemic. The Office of Grants and Debarment tracked grants that received flexibilities through its issued class waivers and regulatory exceptions but did not track grants that received flexibilities and exceptions approved by program offices and regions. The lack of agencywide tracking of grant flexibilities and exceptions hindered the Agency’s ability to assess how...
Environmental Protection Agency OIG
Authorized State Hazardous Waste Program Inspections and Operations Were Impacted During Coronavirus Pandemic
The coronavirus pandemic impacted Resource Conservation and Recovery Act state program operations and resulted in fewer inspections.
Office of Management and Budget
Office of Management and Budget Report - Fourth Quarterly Report
The Coronavirus Aid, Relief, and Economic Security (CARES) Act requires the Office of Management and Budget, in consultation with Department of the Treasury, the Council of Economic Advisers, and the Small Business Administration, to issue quarterly reports to Congress and the public on the economic impact of certain coronavirus funds. This is the fourth quarterly report issued.
Environmental Protection Agency OIG
EPA's National Vehicle and Fuel Emissions Laboratory Has Taken Steps to Mitigate Impact of Coronavirus Pandemic on Mobile Source Emission Compliance
This report examines the EPA’s activities to oversee mobile source compliance with clean air laws and regulations during the coronavirus pandemic. It highlights National Vehicle and Fuel Emissions Laboratory’s efforts to minimize the potential for noncompliance during the pandemic and the importance of returning to full testing capacity to provide the most effective oversight.